Price to Earnings (P/E)
since 2005
Calculation
Abbott Laboratories, P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net earnings1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | 17.46 | = | 134.92 | ÷ | 7.73 | 7.73 | = | 13,402 | ÷ | 1,734,323,411 | |
| Feb 16, 2024 | 34.57 | = | 114.01 | ÷ | 3.30 | 3.30 | = | 5,723 | ÷ | 1,735,184,289 | |
| Feb 17, 2023 | 26.76 | = | 106.74 | ÷ | 3.99 | 3.99 | = | 6,933 | ÷ | 1,737,946,233 | |
| Feb 18, 2022 | 29.13 | = | 116.79 | ÷ | 4.01 | 4.01 | = | 7,071 | ÷ | 1,763,482,267 | |
| Feb 19, 2021 | 48.49 | = | 123.04 | ÷ | 2.54 | 2.54 | = | 4,495 | ÷ | 1,771,529,358 | |
| Feb 21, 2020 | 41.83 | = | 87.45 | ÷ | 2.09 | 2.09 | = | 3,687 | ÷ | 1,763,433,243 | |
| Feb 22, 2019 | 56.47 | = | 76.13 | ÷ | 1.35 | 1.35 | = | 2,368 | ÷ | 1,756,470,269 | |
| Feb 16, 2018 | 220.29 | = | 60.17 | ÷ | 0.27 | 0.27 | = | 477 | ÷ | 1,746,333,892 | |
| Feb 17, 2017 | 55.16 | = | 44.69 | ÷ | 0.81 | 0.81 | = | 1,400 | ÷ | 1,727,997,596 | |
| Feb 19, 2016 | 12.83 | = | 38.53 | ÷ | 3.00 | 3.00 | = | 4,423 | ÷ | 1,473,241,861 | |
| Feb 27, 2015 | 31.30 | = | 47.37 | ÷ | 1.51 | 1.51 | = | 2,284 | ÷ | 1,508,977,828 | |
| Feb 21, 2014 | 23.25 | = | 38.82 | ÷ | 1.67 | 1.67 | = | 2,576 | ÷ | 1,543,070,300 | |
| Feb 15, 2013 | 9.24 | = | 35.08 | ÷ | 3.80 | 3.80 | = | 5,963 | ÷ | 1,570,677,029 | |
| Feb 21, 2012 | 18.67 | = | 56.16 | ÷ | 3.01 | 3.01 | = | 4,728 | ÷ | 1,572,356,859 | |
| Feb 18, 2011 | 15.68 | = | 46.88 | ÷ | 2.99 | 2.99 | = | 4,626 | ÷ | 1,547,581,805 | |
| Feb 19, 2010 | 14.69 | = | 54.38 | ÷ | 3.70 | 3.70 | = | 5,746 | ÷ | 1,552,643,385 | |
| Feb 20, 2009 | 17.11 | = | 54.03 | ÷ | 3.16 | 3.16 | = | 4,881 | ÷ | 1,545,382,675 | |
| Feb 19, 2008 | 23.82 | = | 55.57 | ÷ | 2.33 | 2.33 | = | 3,606 | ÷ | 1,545,737,903 | |
| Feb 23, 2007 | 48.17 | = | 53.59 | ÷ | 1.11 | 1.11 | = | 1,717 | ÷ | 1,543,073,501 | |
| Feb 22, 2006 | 20.03 | = | 43.90 | ÷ | 2.19 | 2.19 | = | 3,372 | ÷ | 1,538,625,812 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Abbott Laboratories Annual Report.
The analysis of the financial data over the examined periods reveals notable fluctuations and trends in share price, earnings per share (EPS), and the price-to-earnings (P/E) ratio. These metrics each exhibit distinct patterns that may correlate to company performance and market valuation.
- Share Price
- The share price demonstrates variability with both periods of growth and decline. Initially, there was a gradual increase from US$43.9 in early 2006 to a peak above US$56 in early 2008 and 2012. However, intermittent declines appear, notably falling to a low of approximately US$35 in early 2013. From 2014 onward, the share price shows a general upward trend, culminating in a significant rise to US$134.92 by early 2025. This long-term growth indicates strengthening market confidence or improved financial performance over time.
- Earnings Per Share (EPS)
- The EPS data shows considerable volatility throughout, with values fluctuating from a low of US$0.27 in early 2018 to a high of US$7.73 in early 2025. Early years feature moderate EPS levels typically ranging between approximately US$1 and US$4, with several dips, including notably low EPS around 2017 and 2018. Post-2018, EPS generally trends upward, indicating improved profitability with some year-to-year variation. The peak EPS in early 2025 suggests a strong earnings performance in the most recent period.
- Price-to-Earnings (P/E) Ratio
- The P/E ratio exhibits pronounced volatility, reflecting changing investor perceptions relative to earnings. Starting at a moderate level near 20 in 2006, it peaks dramatically at 220 in early 2018, coinciding with a period of very low EPS. Such a high P/E ratio suggests the market price remained relatively high despite weaker earnings, potentially indicating expectations of future growth or market overvaluation during that period. Thereafter, the ratio declines to more moderate levels around 17 by 2025, aligning with improved earnings and a rising share price. Periods with a low P/E ratio around 9 in early 2013 correspond with lower share prices and moderate EPS, indicating a possibly undervalued stock at that time.
Overall, the data points to a company experiencing periods of earnings volatility and fluctuating market valuation, but with clear long-term growth in share price and earnings by the end of the period. The P/E ratio's wide swings highlight times of market uncertainty or changing investor expectations. The recent upward trajectory in both EPS and share price suggests strengthening financial health and improved investor confidence towards the end of the timeline.
Comparison to Competitors
Abbott Laboratories, P/E, long-term trends, comparison to competitors
| Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 17.46 | 17.28 | 14.85 | 87.82 | 27.97 | 29.75 |
| Feb 16, 2024 | 34.57 | 11.47 | 19.80 | 74.11 | 30.94 | 20.53 |
| Feb 17, 2023 | 26.76 | 27.53 | 9,358,713.46 | 64.99 | 23.38 | 22.46 |
| Feb 18, 2022 | 29.13 | 17.39 | 18.13 | 59.94 | 46.56 | 26.03 |
| Feb 19, 2021 | 48.49 | 12.88 | 15.87 | 87.47 | 26.30 | 20.54 |
| Feb 21, 2020 | 41.83 | 14.15 | 15.96 | 48.72 | 28.78 | 20.48 |
| Feb 22, 2019 | 56.47 | — | 21.45 | 53.03 | 37.80 | 21.09 |
| Feb 16, 2018 | 220.29 | 10.69 | 15.44 | 70.95 | 29.96 | 20.77 |
| Feb 17, 2017 | 55.16 | 14.91 | 17.48 | 37.16 | 33.17 | 21.73 |
| Feb 19, 2016 | 12.83 | 18.98 | 12.99 | 34.24 | 40.56 | 18.18 |
| Feb 27, 2015 | 31.30 | 24.64 | 15.29 | 44.77 | 20.75 | 18.50 |
| Feb 21, 2014 | 23.25 | 17.71 | 9.95 | 22.82 | 14.99 | 12.35 |
| Feb 15, 2013 | 9.24 | 16.23 | 7.09 | 35.05 | 10.57 | 10.58 |
| Feb 21, 2012 | 18.67 | 16.66 | 8.36 | 39.05 | 13.37 | 10.78 |
| Feb 18, 2011 | 15.68 | 13.20 | 8.74 | 33.85 | 12.65 | 10.01 |
| Feb 19, 2010 | 14.69 | 12.70 | 5.53 | 54.30 | 17.11 | 9.91 |
| Feb 20, 2009 | 17.11 | 11.72 | 8.26 | 21.99 | 26.02 | 11.66 |
| Feb 19, 2008 | 23.82 | 22.10 | 12.02 | 79.87 | 20.81 | 12.85 |
| Feb 23, 2007 | 48.17 | 19.24 | 16.05 | 58.08 | 21.31 | 17.58 |
| Feb 22, 2006 | 20.03 | 20.64 | 20.66 | 36.68 | 35.12 | 24.20 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Abbott Laboratories, P/E, long-term trends, comparison to sector (health care equipment & services)
| Abbott Laboratories | Health Care Equipment & Services | |
|---|---|---|
| Feb 21, 2025 | 17.46 | 25.63 |
| Feb 16, 2024 | 34.57 | 23.36 |
| Feb 17, 2023 | 26.76 | 1,293,631.64 |
| Feb 18, 2022 | 29.13 | 26.88 |
| Feb 19, 2021 | 48.49 | 24.48 |
| Feb 21, 2020 | 41.83 | 23.12 |
| Feb 22, 2019 | 56.47 | 33.08 |
| Feb 16, 2018 | 220.29 | 23.75 |
| Feb 17, 2017 | 55.16 | 24.26 |
| Feb 19, 2016 | 12.83 | 19.90 |
| Feb 27, 2015 | 31.30 | 22.12 |
| Feb 21, 2014 | 23.25 | 15.59 |
| Feb 15, 2013 | 9.24 | 11.51 |
| Feb 21, 2012 | 18.67 | 14.53 |
| Feb 18, 2011 | 15.68 | 12.68 |
| Feb 19, 2010 | 14.69 | 12.01 |
| Feb 20, 2009 | 17.11 | 14.94 |
| Feb 19, 2008 | 23.82 | 18.27 |
| Feb 23, 2007 | 48.17 | 22.40 |
| Feb 22, 2006 | 20.03 | 23.69 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Abbott Laboratories, P/E, long-term trends, comparison to industry (health care)
| Abbott Laboratories | Health Care | |
|---|---|---|
| Feb 21, 2025 | 17.46 | 37.14 |
| Feb 16, 2024 | 34.57 | 29.43 |
| Feb 17, 2023 | 26.76 | 342,408.13 |
| Feb 18, 2022 | 29.13 | 21.35 |
| Feb 19, 2021 | 48.49 | 30.75 |
| Feb 21, 2020 | 41.83 | 21.64 |
| Feb 22, 2019 | 56.47 | 25.29 |
| Feb 16, 2018 | 220.29 | 30.93 |
| Feb 17, 2017 | 55.16 | 21.47 |
| Feb 19, 2016 | 12.83 | 19.50 |
| Feb 27, 2015 | 31.30 | 21.56 |
| Feb 21, 2014 | 23.25 | 18.62 |
| Feb 15, 2013 | 9.24 | 15.80 |
| Feb 21, 2012 | 18.67 | 15.84 |
| Feb 18, 2011 | 15.68 | 15.00 |
| Feb 19, 2010 | 14.69 | 11.75 |
| Feb 20, 2009 | 17.11 | 12.99 |
| Feb 19, 2008 | 23.82 | 19.44 |
| Feb 23, 2007 | 48.17 | 18.63 |
| Feb 22, 2006 | 20.03 | 21.68 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).